3 results
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free Survival ... #EBM #Honc #Osimertinib ... #NSCLC #Survival ... #NEJM
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - Recurrence-free Survival in the
Adjuvant Nivolumab ... Recurrence-free Survival ... Intention-to-Treat Population #EBM ... #Honc #Nivolumab ... Ipilimumab #Melanoma #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
Progression-free Survival ... #EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM